Beyond Air (XAIR) EPS (Diluted) Growth (1y) (2018 - 2026)
Beyond Air (XAIR) EPS (Diluted) Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.91 Bn | 176.62 Bn | 6.27 Bn | -18.71% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 13.88% |
| 3 | Medtronic | 108.72 Bn | 99.50 Bn | 6.41 Bn | 18.72% |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 98.71% |
| 5 | Edwards Lifesciences | 48.53 Bn | 44.85 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn | 95.96% |
| 7 | GE HealthCare Technologies | 28.34 Bn | 26.06 Bn | 1.98 Bn | -29.80% |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.47 Bn | 22.34 Bn | 2.07 Bn | 114.19% |
| 10 | Beyond Air | 2.14 Mn | -10.22 Mn | 94,000.00 | -112.39% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.39% |
| Dec 31, 2025 | 70.75% |
| Sep 30, 2025 | 78.18% |
| Jun 30, 2025 | 71.68% |
| Mar 31, 2025 | 214.81% |
| Dec 31, 2024 | 71.52% |
| Sep 30, 2024 | 45.67% |
| Jun 30, 2024 | 40.71% |
| Mar 31, 2024 | 5.23% |
| Dec 31, 2023 | 57.58% |
| Sep 30, 2023 | 35.45% |
| Jun 30, 2023 | 21.71% |
| Mar 31, 2023 | 80.74% |
| Dec 31, 2022 | 57.58% |
| Sep 30, 2022 | 77.75% |
| Jun 30, 2022 | 60.27% |
| Mar 31, 2022 | -316.96% |
| Dec 31, 2021 | -335.14% |
| Sep 30, 2021 | -395.76% |
| Jun 30, 2021 | 8.89% |